MedPath

Ciprofloxacin

Ciprofloxacin-Mylan

Approved
Approval ID

a974ef05-1cc3-4cbc-a0b4-36b46ed107c9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 19, 2011

Manufacturers
FDA

Legacy Pharmaceutical Packaging

DUNS: 143213275

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ciprofloxacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68645-060
Application NumberANDA075817
Product Classification
M
Marketing Category
C73584
G
Generic Name
ciprofloxacin
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 19, 2011
FDA Product Classification

INGREDIENTS (11)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYDEXTROSEInactive
Code: VH2XOU12IE
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
CIPROFLOXACIN HYDROCHLORIDEActive
Quantity: 500 mg in 1 1
Code: 4BA73M5E37
Classification: ACTIM
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ciprofloxacin - FDA Drug Approval Details